Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic Arthritis

NCT06437392 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2024-05-31

No results posted yet for this study

Summary

The purpose of the study is identify the prevalence of sarcopenia and its associated factors in patients with psoriatic arthritis. Furthermore, we aimed to investigate the predictive contribution of USG in diagnosing sarcopenia by assessing the thickness of the rectus femoris, vastus intermedius, and quadriceps muscles in patients with psoriatic arthritis.

Conditions

Sponsors & Collaborators

  • Ankara City Hospital Bilkent

    lead OTHER

Principal Investigators

  • Gonca Canan Dogan Tosun, Medical Doctor · Ankara City Hospital Bilkent

  • Tuba Güler, Assoc Prof · Ankara City Hospital Bilkent

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-20
Primary Completion
2024-08-20
Completion
2024-08-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06437392 on ClinicalTrials.gov